AI assistant
IDEX Biometrics ASA — AGM Information 2018
May 9, 2018
3633_rns_2018-05-09_62107479-d5d1-4e04-b870-fdc51b968e49.html
AGM Information
Open in viewerOpens in your device viewer
Annual general meeting in IDEX held on 9 May 2018
Annual general meeting in IDEX held on 9 May 2018
Oslo, Norway - 9 May 2018 - IDEX ASA, held its annual general meeting on 9 May
All resolutions were made in accordance with the proposals by the board and the
nomination committee in the notice calling the meeting, issued on 18 April 2018
and 8 May 2018.
Mr Morten Opstad continues as chairman of the Board for the second year of his
term, while Ms Deborah Davis, Ms Hanne Høvding and Mr Lawrence John Ciaccia
continue as board members for their second year of their terms. Mr Andrew James
MacLeod was re-elected as board member for a period of two years. Following the
annual general meeting, the board consists of chairman Morten Opstad, and board
members Larry Ciaccia, Deborah Davis, Hanne Høvding and Andy MacLeod.
The members of the nomination committee continues for the second year of their
term. The nomination committee consists of chairman Harald Voigt and members
Robert N. Keith and Rune Sundvall.
Contact:
Charlotte Knudsen, Director of IR and Communications,
+47 9756 1959, [email protected]
About IDEX ASA:
IDEX is a leading developer of advanced off-chip fingerprint sensors and
complete system solutions to a range of biometrically-enabled applications,
including smart cards, Internet of Things (IoT) and mobile. The company's
technology is based on a fundamentally unique architecture that delivers form
factor flexibility and superior cost-performance characteristics. IDEX's total
addressable market represents a fast-growing multi-billion unit opportunity.
IDEX ASA is traded on the Oslo stock exchange under the ticker IDEX.
For more information, please visit www.idexbiometrics.com and follow us on
Twitter @IDEXASA
This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.